IRS Opens Probe Into Drugmaker-Funded Charity (Audio)

(Bloomberg) -- Robert Langreth, a reporter for Bloomberg News, discusses a new IRS probe into the tax-exempt status of a charity funded by pharmaceutical companies, which threatens a pipeline allowing pharmaceutical companies to help patients pay for expensive drugs. He speaks with Greg Stohr and June Grasso on Bloomberg Radio's "Bloomberg Law."